
    
      1. Cohort 1: To investigate the pharmacokinetics and pharmacodynamics of CJ-12420 after the
           multiple dose administration in H. pylori negative volunteers.

        2. Cohort 2: To investigate the pharmacokinetics and pharmacodynamics of CJ-12420 after the
           single dose administration in H. pylori positive volunteers.
    
  